Cargando…
A Single Site Population Study to Investigate CYP2D6 Phenotype of Patients with Persistent Non-Malignant Pain
Background and Objectives: Codeine requires biotransformation by the CYP2D6 enzyme, encoded by the polymorphic CYP2D6 gene, to morphine for therapeutic efficacy. CYP2D6 phenotypes of poor, intermediate, and ultra-rapid metabolisers are at risk of codeine non-response and adverse drug reactions due t...
Autores principales: | Radford, Helen, Simpson, Karen H., Rogerson, Suzanne, Johnson, Mark I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631257/ https://www.ncbi.nlm.nih.gov/pubmed/31141989 http://dx.doi.org/10.3390/medicina55060220 |
Ejemplares similares
-
Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing
por: Cavallari, Larisa H., et al.
Publicado: (2019) -
Neuroleptic malignant syndrome in an adolescent with CYP2D6 deficiency
por: Butwicka, Agnieszka, et al.
Publicado: (2013) -
Distribution of CYP2D6 Alleles and Phenotypes in the Brazilian Population
por: Friedrich, Deise C., et al.
Publicado: (2014) -
The impact of CYP2D6*41 on CYP2D6 enzyme activity using phenotyping methods in urine, plasma, and saliva
por: Jin, Ye, et al.
Publicado: (2022) -
META-ANALYSIS OF CYP2D6 METABOLIZER PHENOTYPE AND METOPROLOL PHARMACOKINETICS
por: Blake, CM, et al.
Publicado: (2013)